Where does gating uncertainty enter a functional VUS assay?
This paper reports an optimized flow-cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia. From the title alone, I cannot tell how much the functional assignment depends on gate placement. Which controls define the negative, reference, and intermediate populations, and was the final interpretation stable when those gates were shifted? Compensation controls and fluorescence-minus-one controls would answer different parts of that question when signals overlap.
